← OPKO HEALTH, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($25.1m) | ($308.9m) | ($153.0m) | ($314.9m) | $30.6m | ($30.1m) | ($328.4m) | ($188.9m) | ($53.2m) | ($225.7m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $96.6m | $102.1m | $97.3m | $93.8m | $85.4m | $78.7m | $108.7m | $105.3m | $98.2m | $91.6m | $89.7m | |
| Depreciation | $33.3m | $30.6m | $29.4m | $29.0m | $29.0m | $28.4m | $20.9m | $19.3m | $15.6m | $13.7m | $89.7m | |
| Amortization of Debt Issuance Costs | $237k | $224k | $187k | $995k | $847k | $785k | $1.2m | $1.2m | $2.0m | $5.2m | — | |
| Amortization of Intangible Assets | $64.4m | $84.7m | $67.9m | $64.8m | $56.4m | $50.3m | $87.8m | $86.0m | $82.6m | $77.9m | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $108.7m | $105.3m | $98.2m | $91.6m | $89.7m | |
| Deferred Income Tax Expense (Benefit) | ($61.5m) | $16.1m | ($35.1m) | $4.3m | $15.6m | $10.2m | ($74.4m) | $146k | $14.7m | ($15.0m) | ($6.0m) | |
| Deferred Tax | — | — | — | — | — | — | ($74.4m) | $146k | $14.7m | ($15.0m) | ($6.0m) | |
| Share-based Payment Arrangement, Noncash Expense | $42.7m | $28.3m | $21.8m | $13.4m | $8.9m | $13.6m | $18.5m | $11.4m | $11.0m | $10.7m | $10.9m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | $11.4m | $11.0m | $10.7m | $10.9m | |
| Goodwill, Impairment Loss | — | — | $11.7m | $26.2m | $0 | $0 | — | — | — | $0 | $1.0m | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | — | $0 | $0 | $1.0m | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | $13.2m | — | — | — | — | — | — | — | — | — | |
| Asset Impairment Charge | — | — | — | — | — | $0 | — | $0 | $0 | $1.0m | $1.0m | |
| Income (Loss) from Equity Method Investments | ($7.7m) | ($14.5m) | ($14.5m) | — | — | ($629k) | ($383k) | ($107k) | ($18k) | ($29k) | — | |
| Nonoperating Income (Expense) | ($271k) | $4.5m | ($6.1m) | ($30.9m) | ($9.0m) | ($32.8m) | ($165.3m) | ($27.3m) | $141.7m | ($124.0m) | — | |
| Other Nonoperating Income (Expense) | $3.9m | $10.5m | $1.5m | ($11.3m) | $12.7m | ($14.8m) | ($155.8m) | ($17.0m) | $206.9m | ($29.9m) | — | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | $383k | $107k | $18k | $29k | $22k | |
| Changes in operating assets and liabilities: | ||||||||||||
| Change In Working Capital | — | — | — | — | — | — | $42.7m | $21.8m | $32.2m | ($41.2m) | ($10.6m) | |
| Increase (Decrease) in Accounts Receivable | $25.6m | ($58.0m) | ($20.4m) | ($7.4m) | $150.4m | ($5.2m) | ($128.6m) | ($3.4m) | $220k | ($30.2m) | $18.2m | |
| Change In Receivables | — | — | — | — | — | — | $128.6m | $3.4m | ($220k) | $30.2m | $18.2m | |
| Changes In Account Receivables | — | — | — | — | — | — | $128.6m | $3.4m | ($220k) | $30.2m | $18.2m | |
| Increase (Decrease) in Inventories | $6.6m | $3.5m | ($4.6m) | $12.1m | $77.6m | ($30.7m) | ($13.7m) | ($15.2m) | ($4.2m) | $4.1m | $4.8m | |
| Inventory Write-down | $0 | $5.4m | $1.9m | $2.3m | $4.4m | $6.5m | $4.1m | $8.1m | $2.1m | $4.1m | — | |
| Change In Inventory | — | — | — | — | — | — | $13.7m | $15.2m | $4.2m | ($4.1m) | $4.8m | |
| Increase (Decrease) in Accounts Payable | ($19.8m) | $20.2m | ($26.1m) | $15.6m | $37.2m | ($10.8m) | ($9.4m) | $2.8m | ($20.7m) | ($14.2m) | ($13.4m) | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | ($100.5m) | ($2.6m) | $28.0m | ($62.1m) | ($13.4m) | |
| Change In Accrued Expense | — | — | — | — | — | — | ($91.1m) | ($5.5m) | $48.7m | ($47.8m) | ($20.7m) | |
| Gain (Loss) on Disposition of Other Assets | $2.3m | ($8.7m) | $46k | $739k | ($10.7m) | ($33.9m) | $18.6m | $0 | $121.5m | $101.6m | — | |
| Change In Other Current Assets | — | — | — | — | — | — | ($1.5m) | $6.9m | ($3.7m) | ($5.4m) | ($2.0m) | |
| Net Cash Provided by (Used in) Operating Activities | $32.0m |
($92.1m)
-387.34%
|
($109.1m)
-18.53%
|
($172.5m)
-58.07%
|
$39.5m
+122.88%
|
$38.3m
-2.89%
|
($95.2m)
-348.30%
|
($28.2m)
+70.38%
|
($183.5m)
-550.74%
|
($178.5m)
+2.70%
|
($123.4m)
+30.90%
|
|
| Cash flows from investing activities: | ||||||||||||
| Gain (Loss) on Disposition of Property Plant Equipment | $1.4m | $7.3m | $1.2m | $671k | $245k | $31.5m | $2.0m | $2.7m | $242k | $287k | ($113.5m) | |
| Capital Expenditure | $18.5m | $46.5m | $27.9m | $12.7m | $33.7m | $32.2m | ($24.6m) | ($16.3m) | ($25.0m) | ($12.3m) | ($10.6m) | |
| Gain (Loss) on Investments | ($7.7m) | ($14.5m) | ($14.5m) | ($2.9m) | ($480k) | ($629k) | ($383k) | ($107k) | — | — | — | |
| Gain (Loss) on Sale of Investments | ($2.3m) | $8.7m | ($113k) | $0 | — | — | $18.6m | $0 | — | — | — | |
| Payments to Acquire Investments | $14.4m | $9.6m | $1.0m | $1.2m | $0 | $2.0m | $0 | $5.0m | $0 | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | ($15.9m) | $0 | $0 | $0 | $0 | $4.0m | $1.8m | $0 | $0 | — | $0 | |
| Payments for (Proceeds from) Other Investing Activities | $0 | ($2.2m) | — | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($20.7m) | ($46.7m) | ($26.1m) | ($13.3m) | ($18.3m) | $35.9m | $91.0m | ($18.2m) | $352.2m | $230.3m | $206.3m | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | ($284k) | $0 | $0 | — | — | — | — | — | — | — | — | |
| Induced Conversion of Convertible Debt Expense | — | — | — | — | — | — | — | $0 | $0 | $32.6m | — | |
| Issuance Of Debt | — | — | — | — | — | — | $1.1b | $671.7m | $939.4m | $33.0m | $709.4m | |
| Long Term Debt Issuance | — | — | — | — | — | — | $1.1b | $671.7m | $939.4m | $33.0m | $709.4m | |
| Long Term Debt Payments | — | — | — | — | — | — | ($1.0b) | ($682.7m) | ($651.5m) | ($103.8m) | ($41.4m) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $23.7m | ($11.0m) | $288.0m | ($70.8m) | ($5.7m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $23.7m | ($11.0m) | $288.0m | ($70.8m) | ($8.4m) | |
| Repayment Of Debt | — | — | — | — | — | — | ($1.0b) | ($682.7m) | ($651.5m) | ($103.8m) | ($41.4m) | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | — | — | $90.2m | $47.0m | — | |
| Proceeds from Issuance of Common Stock | — | — | $92.5m | $76.1m | $0 | $0 | $221.7m | $0 | $0 | — | — | |
| Common Stock Payments | — | — | — | — | — | — | $0 | $0 | ($90.2m) | ($47.0m) | ($46.6m) | |
| Net Common Stock Issuance | — | — | — | — | — | — | $0 | $0 | ($90.2m) | ($47.0m) | ($46.6m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | $0 | $0 | ($90.2m) | ($47.0m) | ($46.6m) | |
| Net Other Financing Charges | — | — | — | — | — | ($188k) | — | — | ($13.4m) | — | ($13.4m) | |
| Net Cash Provided by (Used in) Financing Activities | ($35.2m) |
$61.0m
+273.44%
|
$140.9m
+130.84%
|
$175.2m
+24.37%
|
($35.1m)
-120.02%
|
($10.4m)
+70.49%
|
$23.0m
+321.92%
|
($11.3m)
-149.21%
|
$184.2m
+1729.36%
|
($118.1m)
-164.10%
|
($52.7m)
+55.34%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($11.0m) | ($13.2m) | $62.5m | $18.5m | ($57.3m) | $349.7m | ($62.9m) | $315.6m | |
| Beginning Cash Position | — | — | — | — | — | — | $134.7m | $153.2m | $95.9m | $445.6m | $285.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $85.5m | $72.2m | $134.7m | $153.2m | $95.9m | $445.6m | $382.7m | $315.6m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | ($477k) | $686k | ($1.4m) | ($339k) | $388k | ($3.2m) | $3.4m | ($1.2m) | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($339k) | $388k | ($3.2m) | $3.4m | ($1.2m) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $2.9m | $1.3m | $2.1m | $11.9m | $10.9m | $8.5m | $7.4m | $8.1m | $20.9m | $37.9m | — | |
| Income Taxes Paid, Net | ($27.1m) | $5.4m | ($1.4m) | $2.7m | ($903k) | $6.0m | $8.0m | $3.7m | $10.0m | $24.5m | — | |
| Additional Financial Items | ||||||||||||
| Deconsolidation, Gain (Loss), Amount | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | $2.3m | ($8.7m) | $46k | $739k | ($10.7m) | ($33.9m) | ($455k) | $1.3m | $121.5m | $101.6m | — | |
| Equity Securities, FV-NI, Gain (Loss) | $2.3m | ($8.7m) | $46k | $739k | $10.4m | ($1.8m) | ($3.6m) | ($532k) | $73.9m | $4.1m | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | $2.3m | ($8.7m) | $2.8m | ($7.4m) | $10.3m | $3.0m | $0 | $0 | ($54.0m) | ($4.3m) | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | $2.3m | — | $2.9m | ($7.4m) | $52k | ($4.8m) | ($3.6m) | ($532k) | $19.8m | ($240k) | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | $800k | $1.4m | $1.9m | $400k | $1.6m | ($1.4m) | ($1.8m) | $1.2m | ($3.8m) | ($2.0m) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $2.8m | $52k | $3.0m | $174k | $50k | $846k | $649k | ($781k) | ($26.2m) | ($429k) | — | |
| Gain (Loss) on Disposition of Assets | $2.3m | ($8.7m) | ($46k) | ($739k) | $10.7m | $33.9m | $455k | ($1.3m) | $63.4m | $3.2m | — | |
| Goodwill | $704.6m | $717.1m | $700.2m | $671.9m | $680.6m | $520.6m | $595.9m | $598.3m | $529.3m | $484.3m | $1.0m | |
| Income Tax Expense (Benefit) | ($56.1m) | $18.9m | ($38.7m) | $7.1m | $17.6m | $15.5m | ($63.5m) | $4.4m | $42.8m | ($15.7m) | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $47.5m | $108.5m | — | |
| Investment Income, Interest | — | — | — | — | — | — | — | $4.0m | $8.4m | $14.8m | — | |
| Operating Expenses | $1.3b | $1.3b | $1.2b | $1.2b | $1.4b | $1.8b | $1.2b | $1.0b | — | — | — | |
| Proceeds from (Payments to) Noncontrolling Interests | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $23.0m | ($11.3m) | $184.2m | ($118.1m) | ($52.7m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | $91.0m | ($18.2m) | $352.2m | $230.3m | $206.3m | |
| Change In Account Payable | — | — | — | — | — | — | ($9.4m) | $2.8m | ($20.7m) | ($14.2m) | ($13.4m) | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $18.5m | ($57.3m) | $349.7m | ($62.9m) | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $2.4m | ($1.0m) | $3.9m | $178k | $2.4m | |
| Change In Payable | — | — | — | — | — | — | ($9.4m) | $2.8m | ($20.7m) | ($14.2m) | ($13.4m) | |
| Changes In Cash | — | — | — | — | — | — | $18.8m | ($57.7m) | $352.9m | ($66.3m) | $30.2m | |
| End Cash Position | — | — | — | — | — | — | $153.2m | $95.9m | $445.6m | $382.7m | $315.6m | |
| Financing Cash Flow | — | — | — | — | — | — | $23.0m |
($11.3m)
-149.21%
|
$184.2m
+1729.36%
|
($118.1m)
-164.10%
|
($52.7m)
+55.34%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($119.8m) | ($44.5m) | ($208.5m) | ($190.8m) | ($134.0m) | |
| Gain Loss On Sale Of Business | — | — | — | — | — | $0 | ($18.6m) | $0 | — | — | — | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | ($455k) | $1.3m | ($63.4m) | ($3.2m) | $728k | |
| Investing Cash Flow | — | — | — | — | — | — | $91.0m | ($18.2m) | $352.2m | $230.3m | $206.3m | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($1.8m) | ($5.0m) | $210.4m | $190.1m | $216.2m | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | $115.4m | $364k | $166.6m | $52.2m | $527k | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | $2.0m | $2.7m | $242k | $287k | $287k | |
| Operating Gains Losses | — | — | — | — | — | — | ($18.6m) | $1.4m | ($184.9m) | ($72.1m) | ($113.5m) | |
| Other Non Cash Items | — | — | — | — | — | — | $2.6m | $2.9m | $12.9m | $71.5m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | ($774k) | ($272k) | ($208k) | ($256k) | ($472k) | |
| Purchase Of Business | — | — | — | — | — | — | ($1.8m) | ($5.0m) | $0 | ($7.7m) | $0 | |
| Sale Of Business | — | — | — | — | — | — | $0 | $0 | $210.4m | $197.8m | $216.2m | |
| Sale Of Investment | — | — | — | — | — | — | $115.4m | $364k | $166.6m | $52.2m | $527k | |
| Sale Of PPE | — | — | — | — | — | — | $2.0m | $2.7m | $242k | $287k | $287k | |
| Stock Based Compensation | — | — | — | — | — | — | $18.5m | $11.4m | $11.0m | $10.7m | $10.9m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | — | — | $153.8m | $17.6m | ($114.4m) | $623k | $470k |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.